Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $9.8 million.

  • Nurix Therapeutics' Prepaid Assets rose 47.34% to $11.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $11.8 million, marking a year-over-year increase of 47.34%. This contributed to the annual value of $9.8 million for FY2024, which is 29.08% up from last year.
  • Nurix Therapeutics' Prepaid Assets amounted to $9.8 million in FY2024, which was up 29.08% from $7.6 million recorded in FY2023.
  • Nurix Therapeutics' 5-year Prepaid Assets high stood at $9.8 million for FY2024, and its period low was $5.9 million during FY2020.
  • For the 3-year period, Nurix Therapeutics' Prepaid Assets averaged around $8.9 million, with its median value being $9.3 million (2022).
  • As far as peak fluctuations go, Nurix Therapeutics' Prepaid Assets soared by 263.53% in 2020, and later dropped by 18.40% in 2023.
  • Yearly analysis of 5 years shows Nurix Therapeutics' Prepaid Assets stood at $5.9 million in 2020, then surged by 54.78% to $9.2 million in 2021, then rose by 1.24% to $9.3 million in 2022, then dropped by 18.40% to $7.6 million in 2023, then climbed by 29.08% to $9.8 million in 2024.